FDA wants $7.2B for product safety, public health in Biden’s FY 2025 budget
Regulatory NewsJeff Craven
Biologics/ biosimilars/ vaccinesDiagnostics/IVDsGenericsMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesRegulatory NewsJeff CravenBiologics/ biosimilars/ vaccinesDiagnostics/IVDsGenericsMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited States